Graph Therapeutics
A next-generation techbio company developing precision medicines for inflammatory and immune-mediated diseases
Graph Therapeutics has raised €4.4M across 1 funding round from 1 investor, most recently a round in Jun 2026. Based in Vienna, Austria; active in Healthtech. Data as of 28 Oct 2026.
Vienna, Austriawww.graphtx.com ↗
Total raised
€4.4M
€4,364,525
Funding rounds
1
Investors
1
distinct backers
Active since
2026-06
latest 2026-06
Funding by year
EUR raised per year · 2026 YTDGraph Therapeutics — funding by year — interactive chart.
Data table
| Graph Therapeutics — funding by year | |
|---|---|
| 2026 | €4.4M |
Signals
High confidenceRaise-next likelihood21
base rate 30% for Other
- ▼ Raised very recently
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-06-22 | Other | €4.4M | Daphni | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData